Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...

High-dose intravenous vitamin C combined with standard chemotherapy significantly extends survival in patients with metastatic pancreatic cancer. Learn more.

随着KRAS靶向治疗的逐步成熟，结合基因组学和动态监测的综合治疗方案，有望从根本上改变PDAC患者的治疗前景。 胰腺癌（Pancreatic cancer）是全球 ...

Certepetide plus chemotherapy showed signs of efficacy but failed to improve progression-free survival in metastatic PDAC in ...

Interestingly, about 10% of PDAC patients who develop lung metastasis survive longer than those with metastasis to other organs, particularly the liver. In some cases, PDAC patients with untreated ...

Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival ...

Silencing the MICAL2 gene in PDAC cells dramatically slowed the activity of the KRAS signaling pathway ... MICAL2 promotes pancreatic cancer growth and metastasis. Cancer Research. 2025. doi: ...

Surufatinib plus TAS-102 showed promising survival benefits with manageable toxicity in refractory metastatic PDAC patients, ...